The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 3)
Rapid Response Innovation Awards, 2014
A simple, painless and reliable method to detect Parkinson's disease at an early stage is very important to patients, doctors and researchers. Doctors want to help patients early, and scientists want to select patients for their research who will help in development of better drugs. We hope that the changes in electrical activity of hand muscles during handwriting will help in ...
Researchers: Michael Linderman, M.Sc.Eng., B.Sc.
Rapid Response Innovation Awards, 2011
Advances in the knowledge and treatment of Parkinson's disease (PD) are limited by the inability to obtain, grow and study neural cells from the brains of living patients. Small samples of brain tissue may be safely collected from PD patients at the time of deep brain stimulation surgery. The objective of this study is to develop human neural cultures from these brain biopsie...
Researchers: Matthew Olding Hebb, MD, PhD, FRCSC
Therapeutics Development Initiative, 2010
Evaluation of the neuroprotectivity ability of Zymes' water-soluble CoQ10 (WS-CoQ10) in animal models of PD; preclinical validation and dose optimization for clinical study
Coenzyme Q10 is a lipid soluble naturally occurring compound essential for energy production and defence against oxidative stress. Recent clinical studies indicate that it may slow the progression of Parkinson's disease (PD) when used in relatively high doses. Zymes LLC is developing a novel formulation consisting of CoQ10 and vitamin E (WS-CoQ10), licensed from the National ...
Researchers: Shelley B. Weinstock, PhD